Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
about
Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseasesGuanylyl cyclase C signaling axis and colon cancer preventionIncidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease.LPS induces HUVEC angiogenesis in vitro through miR-146a-mediated TGF-β1 inhibition.Swimming attenuates inflammation, oxidative stress, and apoptosis in a rat model of dextran sulfate sodium-induced chronic colitis.Outcome Analysis of Patients with Gallstone Disease Receiving Cholecystectomy: A Population-Based Cohort Study.Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel Disease.Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers.Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs.Microbiota, Immune Subversion, and Chronic Inflammation.The Protective Role of Type I Interferons in the Gastrointestinal Tract.Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer.Two case reports: Colorectal adenocarcinoma in children.Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.A role for the non-receptor tyrosine kinase ACK1 in TNF-alpha-mediated apoptosis and proliferation in human intestinal epithelial caco-2 cells.Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages.Hypoxia-sensitive pathways in intestinal inflammation.Rethinking the bile acid/gut microbiome axis in cancer.Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling.A Challenging Treatment Decision for a Rare Association: Case Report of Familial Turcot Syndrome With Fistulizing Crohn's Disease.Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells.Accumulation of T-helper 22 cells, interleukin-22 and myeloid-derived suppressor cells promotes gastric cancer progression in elderly patients.Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced ColitisThe Complex Puzzle of Interactions Among Functional Food, Gut Microbiota, and Colorectal Cancer-Catenin Regulation in Sporadic Colorectal Carcinogenesis: Not as Simple as APC
P2860
Q28071309-49875E89-5ACF-4B65-8B1E-D5B7E8BA88F0Q28074181-9338293B-5A09-41D9-82B4-AFF0FBB8A58AQ37624501-BEF5B1CA-5CD8-419F-A1EE-FA41A9BF0526Q37685263-B3DF2E96-4C1E-407D-911A-15D9E4505991Q37702533-CCEDA2A5-0C50-4BFB-B912-90E322994C84Q38976225-79AFE973-F6F3-4454-9648-C558B994C6E5Q38978202-037816D5-02F3-4701-9E16-D7D138FD058FQ39025709-8BF059D4-6961-4273-A6A4-D103F2DCF0E2Q39125345-C9A10BE0-4EE9-440A-B2BE-5DE5DEEB64D8Q39145487-BDCCFDB5-72EA-477C-AB3E-5D39126D8C96Q39203697-0E6723D0-2522-4120-AAAD-BD34954E7F0BQ39253724-40936E5A-6EBE-4AC1-8443-8876A89AAD90Q42370272-717789F8-C695-47C6-AA31-C1739FAFC6C4Q47114167-3E6FA18F-36B5-47A4-A98B-8C62F50D27C8Q47668921-DA9AD5E3-7657-4AF0-8CA1-6970B1F80E6FQ47786159-803A2454-8765-46A3-92CA-C5910B15CD20Q47836871-7710B8FD-1073-4FD2-83FD-6F436569FE19Q48165608-91565DA0-3D8C-4354-B891-6EF4D07223D8Q48346681-0A091973-C546-4500-A38A-0F64D2115BD8Q49216860-D3C0F994-C3F5-4EDC-8AAB-EEF86BBB1648Q49283122-A73CAFDD-6E55-4E8C-AAC7-06F5455442EDQ55036265-51C404A7-6C4E-43B4-9025-4E2433BAF33FQ55065364-ED1BEFAC-EB65-4E47-B694-38B463320A73Q55160049-A07FBF18-0233-418A-9A31-16BF0B021D7FQ55285116-0F19B42B-05F0-492B-A183-1FFB8BAFC625Q58763027-D7638CC4-AB05-419A-B97D-B9CC78AC2BE1Q58773124-7E791576-8764-46DE-BE1F-1452B99715D3
P2860
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Inflammatory bowel disease and ...... pression, and cancer treatment
@ast
Inflammatory bowel disease and ...... pression, and cancer treatment
@en
Inflammatory bowel disease and ...... pression, and cancer treatment
@nl
type
label
Inflammatory bowel disease and ...... pression, and cancer treatment
@ast
Inflammatory bowel disease and ...... pression, and cancer treatment
@en
Inflammatory bowel disease and ...... pression, and cancer treatment
@nl
prefLabel
Inflammatory bowel disease and ...... pression, and cancer treatment
@ast
Inflammatory bowel disease and ...... pression, and cancer treatment
@en
Inflammatory bowel disease and ...... pression, and cancer treatment
@nl
P2860
P921
P3181
P356
P1476
Inflammatory bowel disease and ...... pression, and cancer treatment
@en
P2093
Simon Lichtiger
Vijay Yajnik
P2860
P304
P3181
P356
10.3748/WJG.V22.I20.4794
P407
P50
P577
2016-05-01T00:00:00Z